CURI vs LLYVK

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 04, 2026

CURI

41.5
AI Score
VS
LLYVK Wins

LLYVK

51.8
AI Score

Investment Advisor Scores

CURI

42score
Recommendation
HOLD

LLYVK

52score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CURI LLYVK Winner
Forward P/E 9.0334 129.8701 CURI
PEG Ratio 0 0 Tie
Revenue Growth 22.3% 6.1% CURI
Earnings Growth 1400.0% 0.0% CURI
Tradestie Score 41.5/100 51.8/100 LLYVK
Profit Margin 0.0% -108.1% CURI
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CURI 1M: +1.1% · 3M: -2.3% LLYVK 1M: -4.6% · 3M: +6.0%

Current Technical Phase

CURI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.9 · Price: $2.71

LLYVK

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 39

RSI (14): 38.7 · Price: $99.00

Fundamentals Snapshot

Metric CURI LLYVK
Market Cap
Forward P/E 8.7 -29.3
Trailing P/E
Revenue (TTM)
Revenue Growth 0.2% 0.1%
Gross Margin 0.6% 0.2%
Operating Margin 0.4% 0.0%
EPS -0.01 -4.74
Dividend Yield 0.11%

Frequently Asked Questions

Based on our detailed analysis, LLYVK is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.